Form 4: Danaher Corp Executive Brian W. Ellis Reports Stock Option Grant
SEC Form 4 Filing
Brian W. Ellis, Senior Vice President and General Counsel of Danaher Corp, reports the acquisition of 18,910 employee stock options.
Summary
- On March 1, 2025, Brian W. Ellis, a Senior Vice President and General Counsel at Danaher Corp, was granted 18,910 employee stock options with an exercise price of $207.76.
- The options become exercisable in two equal installments on the third and fourth anniversaries of the grant date.
- The options expire on March 1, 2035.
- Following the transaction, Ellis directly owns 18,910 derivative securities.
Sentiment
Score: 7
Explanation: The document reflects a routine executive compensation event, which is generally viewed neutrally to positively as it incentivizes management. The sentiment is therefore moderately positive.
Positives
- The grant of stock options aligns the executive's interests with those of the shareholders.
Industry Context
Stock option grants are a common form of executive compensation in publicly traded companies, used to incentivize performance and align management's interests with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages, including stock options, vary significantly across industries and companies based on factors such as company size, performance, and industry benchmarks.
- Comparing Danaher's executive compensation practices to those of its peers in the industrial and scientific equipment sector would provide a more comprehensive understanding of its relative positioning.
- Companies like Thermo Fisher Scientific, Agilent Technologies, and Siemens are relevant comparables for benchmarking executive compensation.
Stakeholder Impact
- The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
- The grant incentivizes the executive to improve company performance, which could benefit shareholders, employees, and other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of the stock option grant. |
| 03/01/2025 | Vesting start date for the options (one half of the options become exercisable on each of the third and fourth anniversaries of this date). |
| 03/01/2035 | Expiration date of the stock options. |
| 03/04/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.